Szekeres, Ferenc L. M.
Walum, Erik
Wikström, Per
Arner, Anders
Funding for this research was provided by:
Hans-Gabriel och Alice Trolle-Wachtmeisters Stiftelse (2019)
University of Skövde
Article History
Received: 5 March 2021
Accepted: 28 May 2021
First Online: 7 June 2021
Competing interests
: PW and EW and Glucox Biotech AB have no commercial or financial interest in the Nox2/Nox4 inhibitor (GLX481304) that is used in this publication. The compound was developed by the company but is currently not patented. Both PW and EW are owner of stocks in Glucox Biotech AB. Glucox Biotech AB provided support in the form of salaries for the author PW and supplied the compound used. AA and FS have no competing interests to report.